Gedea Biotech Announces CE-Marking for pHyph: A Novel Antibiotic-Free Treatment for Bacterial Vaginosis
Lund, Sweden – September 2, 2025 – Gedea Biotech, an innovative Swedish life science company, today announced that its lead product pHyph has received CE-marking under the EU Medical Device Regulation (MDR) for the treatment of bacterial vaginosis (BV). pHyph is an antibiotic-free vaginal tablet…
